Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Charlotte Goor, BSN, RN, OCN

Advertisement

Articles by Charlotte Goor, BSN, RN, OCN

A Journey Shared: Navigating Cancer as a Caretaker, Nurse, and Patient

ByCharlotte Goor, BSN, RN, OCN
July 9th 2024

An oncology nurse's experience with her mother's cancer and her own BRCA2 diagnosis shapes her approach to patient care.

Advertisement

Latest Updated Articles

  • A Journey Shared: Navigating Cancer as a Caretaker, Nurse, and Patient
    A Journey Shared: Navigating Cancer as a Caretaker, Nurse, and Patient

    July 9th 2024



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses

2

FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses

3

Addressing Financial Toxicity: Team-Based Workflows in Oncology Care

4

Early Amivantamab Experience and Subcutaneous Dosing in COPERNICUS

5

First-Line Treatment Choice and Altering Resistance in EGFR-Mutant NSCLC

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us